CONTEXT: Uncertainties exist about the rates, predictors, and outcomes of major depressive disorder (MDD) among individuals with traumatic brain injury (TBI). OBJECTIVE: To describe MDD-related rates, predictors, outcomes, and treatment during the first year after TBI. DESIGN: Cohort from June 2001 through March 2005 followed up by structured telephone interviews at months 1 through 6, 8, 10, and 12 (data collection ending February 2006). SETTING: Harborview Medical Center, a level I trauma center in Seattle, Washington. PARTICIPANTS: Five hundred fifty-nine consecutively hospitalized adults with complicated mild to severe TBI. MAIN OUTCOME MEASURES: The Patient Health Questionnaire (PHQ) depression and anxiety modules were administered at each assessment and the European Quality of Life measure was given at 12 months. RESULTS: Two hundred ninety-seven of 559 patients (53.1%) met criteria for MDD at least once in the follow-up period. Point prevalences ranged between 31% at 1 month and 21% at 6 months. In a multivariate model, risk of MDD after TBI was associated with MDD at the time of injury (risk ratio [RR], 1.62; 95% confidence interval [CI], 1.37-1.91), history of MDD prior to injury (but not at the time of injury) (RR, 1.54; 95% CI, 1.31-1.82), age (RR, 0.61; 95% CI, 0.44-0.83 for > or = 60 years vs 18-29 years), and lifetime alcohol dependence (RR, 1.34; 95% CI, 1.14-1.57). Those with MDD were more likely to report comorbid anxiety disorders after TBI than those without MDD (60% vs 7%; RR, 8.77; 95% CI, 5.56-13.83). Only 44% of those with MDD received antidepressants or counseling. After adjusting for predictors of MDD, persons with MDD reported lower quality of life at 1 year compared with the nondepressed group. CONCLUSIONS: Among a cohort of patients hospitalized for TBI, 53.1% met criteria for MDD during the first year after TBI. Major depressive disorder was associated with history of MDD and was an independent predictor of poorer health-related quality of life.
CONTEXT: Uncertainties exist about the rates, predictors, and outcomes of major depressive disorder (MDD) among individuals with traumatic brain injury (TBI). OBJECTIVE: To describe MDD-related rates, predictors, outcomes, and treatment during the first year after TBI. DESIGN: Cohort from June 2001 through March 2005 followed up by structured telephone interviews at months 1 through 6, 8, 10, and 12 (data collection ending February 2006). SETTING: Harborview Medical Center, a level I trauma center in Seattle, Washington. PARTICIPANTS: Five hundred fifty-nine consecutively hospitalized adults with complicated mild to severe TBI. MAIN OUTCOME MEASURES: The Patient Health Questionnaire (PHQ) depression and anxiety modules were administered at each assessment and the European Quality of Life measure was given at 12 months. RESULTS: Two hundred ninety-seven of 559 patients (53.1%) met criteria for MDD at least once in the follow-up period. Point prevalences ranged between 31% at 1 month and 21% at 6 months. In a multivariate model, risk of MDD after TBI was associated with MDD at the time of injury (risk ratio [RR], 1.62; 95% confidence interval [CI], 1.37-1.91), history of MDD prior to injury (but not at the time of injury) (RR, 1.54; 95% CI, 1.31-1.82), age (RR, 0.61; 95% CI, 0.44-0.83 for > or = 60 years vs 18-29 years), and lifetime alcohol dependence (RR, 1.34; 95% CI, 1.14-1.57). Those with MDD were more likely to report comorbid anxiety disorders after TBI than those without MDD (60% vs 7%; RR, 8.77; 95% CI, 5.56-13.83). Only 44% of those with MDD received antidepressants or counseling. After adjusting for predictors of MDD, persons with MDD reported lower quality of life at 1 year compared with the nondepressed group. CONCLUSIONS: Among a cohort of patients hospitalized for TBI, 53.1% met criteria for MDD during the first year after TBI. Major depressive disorder was associated with history of MDD and was an independent predictor of poorer health-related quality of life.
Authors: Kathleen R Bell; Nancy R Temkin; Peter C Esselman; Jason N Doctor; Charles H Bombardier; Robert T Fraser; Jeanne M Hoffman; Janet M Powell; Sureyya Dikmen Journal: Arch Phys Med Rehabil Date: 2005-05 Impact factor: 3.966
Authors: Ricardo E Jorge; Robert G Robinson; David Moser; Amane Tateno; Benedicto Crespo-Facorro; Stephan Arndt Journal: Arch Gen Psychiatry Date: 2004-01
Authors: Dawn M Schiehser; Dean C Delis; J Vincent Filoteo; Lisa Delano-Wood; S Duke Han; Amy J Jak; Angela I Drake; Mark W Bondi Journal: J Clin Exp Neuropsychol Date: 2011-07 Impact factor: 2.475
Authors: Patricia M Washington; Patrick A Forcelli; Tiffany Wilkins; David N Zapple; Maia Parsadanian; Mark P Burns Journal: J Neurotrauma Date: 2012-08-03 Impact factor: 5.269
Authors: David C Perry; Virginia E Sturm; Matthew J Peterson; Carl F Pieper; Thomas Bullock; Bradley F Boeve; Bruce L Miller; Kevin M Guskiewicz; Mitchel S Berger; Joel H Kramer; Kathleen A Welsh-Bohmer Journal: J Neurosurg Date: 2015-08-28 Impact factor: 5.115
Authors: Michael K Walls; Nicholas Race; Lingxing Zheng; Sasha M Vega-Alvarez; Glen Acosta; Jonghyuck Park; Riyi Shi Journal: J Neurosurg Date: 2015-08-21 Impact factor: 5.115
Authors: Jordin K Shelley; Jacob W Roden-Foreman; David Vier; Evan Elizabeth McShan; Monica M Bennett; Alan L Jones; Ann Marie Warren Journal: Proc (Bayl Univ Med Cent) Date: 2020-09-02